Incyte Corporation (INCY)
NASDAQ · Healthcare
Incyte Corporation Revenue 2009–2025
Incyte Corporation annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Incyte Corporation revenue for the quarter ending March 31, 2026 was 1.3 B, a 20.87% increase year-over-year.
- Incyte Corporation revenue for the twelve months ending March 31, 2026 was 4.9 B, a 23.25% increase year-over-year.
- Incyte Corporation annual revenue for 2025 was 5.1 B, a 21.22% increase from 2024.
- Incyte Corporation annual revenue for 2024 was 4.2 B, a 14.76% increase from 2023.
- Incyte Corporation annual revenue for 2023 was 3.7 B, a 8.87% increase from 2022.
- Incyte Corporation annual revenue for 2022 was 3.4 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Incyte Corporation Revenue — FAQ
Incyte Corporation (INCY) revenue over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Incyte Corporation's revenue?
Incyte Corporation (INCY) reported revenue of $5.14B for fiscal 2025.
Where can I see INCY's revenue history?
The chart and table above show Incyte Corporation's revenue by year and by quarter, including the growth rate.